Trial Profile
Effect of Denosumab in Reversing Periprosthetic Bone Loss Following Hip Replacement
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms Longjohn
- 07 Nov 2020 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 07 Nov 2020 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
- 07 Nov 2020 Planned initiation date changed from 1 Jun 2015 to 28 Feb 2017.